Integrichain Blog

Blog

Patient Access Mia Scioscia
July 27, 2020

Real-Time Data Insights and Actionability All in Single Access-Specific Platform

4 Minute Read

Refined patient data aggregation and enhanced inventory analytics. Read more about what's new in the latest ICyte Platform Summer Release.

Contracts & Pricing John Whitridge
July 22, 2020

New News From California: Pricing Transparency, State Supplemental Program

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
June 19, 2020

The Latest Updates from the Centers for Medicare & Medicaid Services,...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Patient Access Sean McCarthy Edward Doran
June 10, 2020

The Four Challenge Cases in Patient Data Mastering

8 Minute Read

IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...

Patient Access Lucas Dan
August 15, 2019

Utilizing AI and Machine Learning to Predict Challenging Patient Cases

3 Minute Read

IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...

Contracts & Pricing Gary Palgon
December 12, 2018

Looking to 2019 from the Life Sciences Trade and Channel Strategic...

2 Minute Read

In this post IntegriChain Senior Vice President of Sales, Gary Palgon, shares the trending topic's from the 2018 CBI Life Sciences Trade & Channel conference held in Philadelphia, Pa...

Channel Shivani Patel
August 20, 2018

Opioid Crisis Exposes Vulnerabilities in Suspicious Order Monitoring

4 Minute Read

The American opioid crisis exposed gaps in the reporting systems designed to flag suspicious orders of pharmaceutical products classified as controlled substances. Pharmaceutical manufacturers are now facing increased scrutiny...

Patient Access Sean McCarthy
August 3, 2018

3 Key Opportunities to Improve Specialty Patient Initiation

3 Minute Read

There are several ways specialty brands can improve patient initiation by implementing data-driven patient support strategies. Successful interventions to streamline patient initiation have the potential to speed Time to...

Managed Services David Carlson
July 27, 2018

The Economics of Rare Disease and Implications for Payer Contract Strategy

3 Minute Read

Rare diseases affect 30 million people in the United States, which roughly equates to 10% of the population. In 2017, 40% of the novel drugs approved by the FDA...

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article